American Journal of Cardiology
Volume 103, Issue 6 , Pages 887-890 , 15 March 2009

Effects of Testosterone on Ventricular Repolarization in Hypogonadic Men

  • Beny Charbit, MD

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-9304, Paris, France
    • Department of Pharmacology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
    • Department of Endocrinology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
    • Corresponding Author InformationCorresponding author: Tel: 33-1-49-28-24-04; fax: 33-1-49-28-21-08
  • ,
  • Sophie Christin-Maître, MD, PhD

      Affiliations

    • Department of Pharmacology, Université Pierre et Marie Curie Paris 06, Paris, France
    • Department of Endocrinology, Université Pierre et Marie Curie Paris 06, Paris, France
  • ,
  • Jean-Louis Démolis, MD, PhD

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-9304, Paris, France
    • Department of Pharmacology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
  • ,
  • Elsa Soustre, PharmD

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-9304, Paris, France
    • Department of Pharmacology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
  • ,
  • Jacques Young, MD, PhD

      Affiliations

    • Department of Endocrinology, Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
  • ,
  • Christian Funck-Brentano, MD, PhD

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-9304, Paris, France
    • Department of Pharmacology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
    • Department of Endocrinology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France

Received 18 August 2008 ,Revised 20 November 2008 ,Accepted 20 November 2008.

References 

  1. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992;8:690–695
  2. Mayuga KA, Parker M, Sukthanker ND, Perlowski A, Schwartz JB, Kadish AH. Effects of age and gender on the QT response to exercise. Am J Cardiol. 2001;87:163–167
  3. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for Torsades de Pointes associated with cardiovascular drugs. JAMA. 1993;270:2590–2597
  4. Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation. 1996;94:1471–1474
  5. Hulot JS, Démolis JL, Rivière R, Strabach S, Christin-Maitre S, Funck-Brentano C. Influence of endogenous oestrogens on QT interval duration. Eur Heart J. 2003;24:1663–1667
  6. Burke JH, Ehlert FA, Kruse JT, Parker MA, Goldberger JJ, Kadish AH. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol. 1997;79:178–181
  7. Vrtovec B, Starc V, Meden-Vrtovec H. The effect of estrogen replacement therapy on ventricular repolarization dynamics in healthy postmenopausal women. J Electrocardiol. 2001;34:277–283
  8. Larsen JA, Tung RH, Sadananda R, Goldberger JJ, Horvath G, Parker MA, et al. Effects of hormone replacement therapy on QT interval. Am J Cardiol. 1998;82:993–995
  9. Liu XK, Katchman A, Kruse JT, Parker MA, Woosley RL, Ebert SN. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol. 1997;79:28–36
  10. Bidoggia H, Maciel JP, Capalozza N, Mosca S, Blaksley EJ, Valverde E, et al. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am Heart J. 2000;140:678–683
  11. Lepeschkin E, Surawicz B. The measurement of the QT interval of the electrocardiogram. Circulation. 1952;6:378–388
  12. Funck-Brentano C, Kibleur Y, Le Coz F, Poirier JM, Mallet A, Jaillon P. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation. 1991;83:536–545
  13. Démolis JL, Martel C, Funck-Brentano C, Sachse A, Weimann HJ, Jaillon P. Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers. Br J Clin Pharmacol. 1997;44:403–409
  14. Démolis JL, Strabach S, Vacheron F, Funck-Brentano C. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced QT interval prolongation in healthy women. Br J Clin Pharmacol. 2005;60:120–127
  15. Liu XK, Katchman A, Whitfield BH, Wan G, Janowski EM, Woosley RL, et al. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res. 2003;57:28–36
  16. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation. 2005;112:1701–1710
  17. Pham TV, Sosunov EA, Gainullin RZ, Danilo P, Rosen MR. Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs. Circulation. 2001;103:2207–2212
  18. Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil. 2005;12:363–368
  19. Burger HG. Androgen production in women. Fertil Steril. 2002;77(suppl):S3–S5
  20. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672
  21. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26:833–876
  22. Mohr BA, Guay AT, O'Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf). 2005;62:64–73
  23. Sohaib SM, Papacosta O, Morris RW, Macfarlane PW, Whincup PH. Length of the QT interval: determinants and prognostic implications in a population-based prospective study of older men. J Electrocardiol. 2008;41:704–710
  24. Ebert SN, Liu XK, Woosley RL. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. J Womens Health. 1998;7:547–557
  25. Drici MD, Knollmann BC, Wang WX, Woosley RL. Cardiac actions of erythromycin: influence of female sex. JAMA. 1998;280:1774–1776
  26. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682–688

 This study was supported by a grant-in-aid from INSERM and Assistance Publique - Hôpitaux de Paris at the Clinical Investigation Center of Hôpital Saint-Antoine, Paris, France. The legal sponsor was INSERM (RBM 04-06).

PII: S0002-9149(08)02114-0

doi: 10.1016/j.amjcard.2008.11.041

American Journal of Cardiology
Volume 103, Issue 6 , Pages 887-890 , 15 March 2009